BioCentury
ARTICLE | Clinical News

ANG1005: Interim Phase II data

December 7, 2015 8:00 AM UTC

Interim data from 21 heavily pre-treated breast cancer patients with leptomeningeal carcinomatosis in an open-label, U.S. Phase II trial showed that ANG1005 led to 5 partial responses and 11 cases of ...